CPX351 in Secondary AML?

CPX rather than 3 and 7 but I'll give good thoughts using a sub-vend of those patients even if they're not in the approved indication because they're not over 75 or have a comorbidity. McGrollumab has this unique mechanism of action which everybody loves to say because it inhibits a quote don't eat me unquote signal on the surface of the leukemic cell for that matter other cancer cells. The dosing regimens here varying a little bit according to which cycle is a ramp up during cycle one a little bit more.